Since 2015 we have done extensive testing with several versions. Currently we have ongoing trials in Cambridge. We will launch the first wellness-device in 2020 and continue developing medical versions mainly now targeting anxiety, depression and chronic fatigue.
For the medical device applications, we are currently looking for partnerships to develop adjunctive therapies where our vagus stimulations helps to enhance pharmacological-, neuroplasticity-, behavioural- and physical therapies.